• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT HBSAG QUALITATIVE II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT HBSAG QUALITATIVE II Back to Search Results
Catalog Number 02G22-30
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/27/2020
Event Type  malfunction  
Manufacturer Narrative
There was no further patient information provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 2g22 that has a similar product distributed in the us, list number 4p53.
 
Event Description
The customer observed false nonreactive architect (b)(6) qualitative ii results on one patient.The results were provided: on (b)(6) 2020 sid (b)(6) initial (b)(6) result=0.7497 s/co ( <1.00 s/co= nonreactive) / (previous history=(b)(6) reactive last year) / on (b)(6) 2020 repeated results= 0.7276 s/co ( nonreactive) and 140.4914 s/co (> or =1.00 s/ co=reactive) / confirmatory result c1=0.1067 s/co (na), c2=0.7080 s/co (reactive), n%=114.8148 (confirmed positive).
 
Manufacturer Narrative
A review of tickets was performed for reagent architect hbsag qualitative ii lot number 04361fn00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Historical performance of reagent lot 04361fn00 was evaluated using world wide data from abbottlink.This evaluation indicated that the patient median result for lot 04361fn00 is within the established baseline and comparable with other lot number in the field.Therefore, no unusual reagent lot performance was identified.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no product deficiency was identified for the architect hbsag qualitative ii, lot 04361fn00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HBSAG QUALITATIVE II
Type of Device
HBSAG
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key10082553
MDR Text Key229569025
Report Number3008344661-2020-00038
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/07/2020
Device Catalogue Number02G22-30
Device Lot Number04361FN00
Was Device Available for Evaluation? No
Date Manufacturer Received07/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; ARCHITECT I2000SR ANALYZER; LIST 03M74-65, SERIAL (B)(6) ; LIST 03M74-65, SERIAL # (B)(6)
-
-